A Randomized, Double-Blind, Comparative Therapy Evaluating Sitagliptin Versus Glibenclamide in Type 2 Diabetes Patients Already Treated with Pioglitazone and Metformin: A 3-Year Study
Diabetes Technology & Therapeutics , Vol. 0, No. 0.
Source: Diabetes Technology - Category: Endocrinology Tags: article Source Type: research
More News: Actos | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Janumet | Januvia | Metformin | Study